Clik here to view.
CHINATRIALS 16
Home » CHINATRIALS 16 The CHINATRIALS 16: Clinical Development Leaders’ Summit returns to Shanghai on November 11-13, 2024 and will again provide the year’s best opportunity to share China clinical...
View ArticleClik here to view.
9th Annual Clinical Trial Supply East Asia 2024
Home » 9th Annual Clinical Trial Supply East Asia 2024 The leading clinical outsourcing conference in East Asia is returning in 2024. With a focus on providing delegates with practical take-aways and...
View ArticleClik here to view.
Q&A Article-Fundamentals of Particle Size Analysis
Home » Formulation and Evaluation of Enteric Coated Aspirin Capsules Summary: Micronization, the process of reducing the size of active pharmaceutical ingredient (API) particles to micrometer scale,...
View ArticleClik here to view.
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
Home » Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility Oct 14, 2024 – Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for...
View ArticleClik here to view.
Drug Delivery to the Lungs 2024
Home » Drug Delivery to the Lungs 2024 Drug Delivery to the Lungs (DDL) is a premier conference dedicated to pulmonary and nasal drug delivery and brings together leading scientists, academics,...
View ArticleClik here to view.
Catalent Issues Open Letter to Customers Regarding Pending Acquisition by...
Home » Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings Committed to Continuing to Serve Customers and Patients as a Leading Global, Independent, Full-Service...
View ArticleClik here to view.
Oral Lipid-Based Formulations: Unlocking Value in Early-Stage Pharmaceutical...
Home » Oral Lipid-Based Formulations: Unlocking Value in Early-Stage Pharmaceutical Development Summary: Lipid-based formulations are more than just a tool for enhancing solubility and...
View ArticleClik here to view.
IsomAb Announces Strategic Collaboration with Catalent
Home » IsomAb Announces Strategic Collaboration with Catalent Master Service Agreement for ISM-001 First work program initiated August 2024 Strategic collaboration encompassing initial process...
View ArticleClik here to view.
Leveraging Platform Processes for Developing and Accelerating Novel Gene and...
Home » Leveraging Platform Processes for Developing and Accelerating Novel Gene and Cancer Therapeutics Date: December 5, 2024 Time: 11:00am ET This year, the long-awaited FDA draft guidance for...
View ArticleClik here to view.
Navigating Preclinical Drug Development Challenges with Lipid-Based Formulations
Home » Navigating Preclinical Drug Development Challenges with Lipid-Based Formulations Summary: Download this executive summary to explore key insights from industry experts on critical...
View Article